Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SNAI2 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the messenger RNA encoding the Snail family transcriptional repressor 2, also known as Slug (UniProt: O43623). This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that control the stability and translation efficiency of the SNAI2 transcript. SNAI2 is a master regulator of the epithelial-mesenchymal transition (EMT), a process essential for embryonic development but frequently hijacked by cancer cells to promote invasion, metastasis, and resistance to therapy (PMID: 23568941). By targeting the SNAI2 mRNA 3′UTR with miRNA mimics or antisense oligonucleotides, researchers aim to suppress SNAI2 expression and reverse the EMT phenotype in aggressive tumors. Endogenous miRNAs such as miR-1, miR-124, and miR-203 naturally bind to this region to downregulate SNAI2, and their loss is often associated with poor prognosis in various malignancies (PMID: 21460138, PMID: 23873011). Consequently, this regulatory region represents a promising therapeutic target for preventing cancer progression and overcoming chemoresistance through RNA-based interventions.
Binding of complementary RNA sequences, such as microRNA (miRNA) mimics or antisense oligonucleotides (ASOs), to specific seed sequences within the 3′UTR leads to the recruitment of the RNA-induced silencing complex (RISC), resulting in mRNA degradation or translational inhibition of the SNAI2 transcript (PMID: 20802496, PMID: 21460138).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Snail family transcriptional repressor 2 mRNA 3′ untranslated region (SNAI2 mRNA 3′UTR).